NHP Covid Patient Info on vaccination

CSL Behring‘s HEMOPEXIN FIRST IN HUMAN STUDY IN STABLE SICKLE DISEASE Study Title: A Phase 1, Multi-Center, Open Label, Single Ascending Dose Study to Evaluate

Thalassaemia Questionnaire

If your a patient that suffers from Sickle Cell or Thalassaemia or even knows somebody that does, then we would love to hear from you.

We are currently researching what new services people with SCD and their families would like, including services that address the impact that Covid 19 may